Literature DB >> 9470804

Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.

M Clemons1, M Leahy, J Valle, G Jayson, M Ranson, A Howell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470804     DOI: 10.1016/s0959-8049(97)00260-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.

Authors:  J P Galons; M I Altbach; G D Paine-Murrieta; C W Taylor; R J Gillies
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.

Authors:  Ozlem Darcansoy Işeri; Meltem Demirel Kars; Ufuk Gündüz
Journal:  Mol Biol Rep       Date:  2011-07-01       Impact factor: 2.316

Review 3.  The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies.

Authors:  Jordyn Kreutzfeldt; Brett Rozeboom; Nandini Dey; Pradip De
Journal:  Am J Cancer Res       Date:  2020-04-01       Impact factor: 6.166

Review 4.  Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.

Authors:  Jesse Yu; Qingxin Mu; Millie Fung; Xiaolin Xu; Linxi Zhu; Rodney J Y Ho
Journal:  Pharmacol Ther       Date:  2022-01-06       Impact factor: 13.400

Review 5.  MR cell size imaging with temporal diffusion spectroscopy.

Authors:  Xiaoyu Jiang; Hua Li; Sean P Devan; John C Gore; Junzhong Xu
Journal:  Magn Reson Imaging       Date:  2020-12-16       Impact factor: 2.546

6.  Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.

Authors:  A C Humphreys; J Dent; S Rodwell; S M Crawford; J K Joffe; C Bradley; D Dodwell; T J Perren
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.